medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2023, Number 1

<< Back Next >>

Rev Mex Urol 2023; 83 (1)

Laparoscopic radical cystectomy in a patient with second primary post-robot-assisted radical prostatectomy

Zapata-González JA, García-Hernández S, De la Santis García-Velandria FA, Álvarez-Álvarez JJ, Alarcón-Salvador JF

Language: Spanish
References: 17
Page:
PDF size: 259.95 Kb.


ABSTRACT

Case description: It describes the etiology, clinical scenario, and diagnosis of a patient with primary bulbar urethral carcinoma with history of a prostate cancer treated by Robot-assisted radical prostatectomy, actually treated with cystectomy, intracorporeal ileal conduit by laparoscopy, and total urethrectomy.
Relevance: Very few reported cases in medical literature and the important benefits of the minimally invasive surgery we observed in our work center in patients with a history of surgical interventions.
Clinical implications: Importance of narrow oncological surveillance and the benefit in postoperative recovery of a patient treated by minimal invasive procedures.
Conclusions: Every patient with an oncological diagnosis must have a narrow follow to detect the recurrence of the primary disease or new disease in a different place and if possible, always offer our patient a minimally invasive approach to diminish morbidity and mortality rate.


REFERENCES

  1. Visser O, Adolfsson J, Rossi S, Verne J, GattaG, Maffezzini M, et al. Incidence and survivalof rare urogenital cancers in Europe. EuropeanJournal of Cancer. 2012;48(4):456–64. doi:https://doi.org/10.1016/j.ejca.2011.10.031

  2. Swartz MA, Porter MP, Lin DW, Weiss NS.Incidence of primary urethral carcinoma in theUnited States. Urology. 2006;68(6):1164–8. doi:https://doi.org/10.1016/j.urology.2006.08.1057

  3. Van de Voorde W, Meertens B, BaertL, Lauweryns J. Urethral squamous cellcarcinoma associated with urethral strictureand urethroplasty. Eur J Surg Oncol.1994;20(4):478–83.

  4. Cupp MR, Malek RS, Goellner JR, Espy MJ, SmithTF. Detection of human papillomavirus DNA inprimary squamous cell carcinoma of the maleurethra. Urology. 1996;48(4):551–5. doi: https://doi.org/10.1016/S0090-4295(96)00246-4

  5. Compérat E, Varinot J. Immunochemical andmolecular assessment of urothelial neoplasms andaspects of the 2016 World Health Organizationclassification. Histopathology. 2016;69(5):717–26. doi: https://doi.org/10.1111/his.13025

  6. Brierley JD, Gospodarowicz MK, Wittekind C.TNM Classification of Malignant Tumours. 8thed. Wiley-Blackwell; 2017. 272 p.

  7. Gheiler EL, Tefilli MV, Tiguert R, Oliveira JG de,Pontes JE, Wood DP. Management of primaryurethral cancer. Urology. 1998;52(3):487–93. doi: https://doi.org/10.1016/S0090-4295(98)00199-X

  8. Touijer AK, Dalbagni G. Role of voided urinecytology in diagnosing primary urethralcarcinoma. Urology. 2004;63(1):33–5. doi:https://doi.org/10.1016/j.urology.2003.08.007

  9. Donat SM, Wei DC, McGuire MS, HerrHW. The efficacy of transurethral biopsyfor predicting the long-term clinical impactof prostatic invasive bladder cancer. J Urol.2001;165(5):1580–4. doi: https://doi.org/10.1097/00005392-200105000-00039

  10. Kakizoe T, Tobisu K. Transitional CellCarcinoma of the Urethra in Men and WomenAssociated with Bladder Cancer. JapaneseJournal of Clinical Oncology. 1998;28(6):357–9.doi: https://doi.org/10.1093/jjco/28.6.357

  11. Gakis G, Witjes JA, Compérat E, Cowan NC,De Santis M, Lebret T, et al. EAU Guidelineson Primary Urethral Carcinoma. EuropeanUrology. 2013 Nov 1;64(5):823–30. doi: https://doi.org/10.1016/j.eururo.2013.03.044

  12. Spiess PE, Agarwal N, Bangs R, Boorjian SA,Buyyounouski MK, Clark PE, et al. BladderCancer, Version 5.2017, NCCN ClinicalPractice Guidelines in Oncology. Journal ofthe National Comprehensive Cancer Network.2017;15(10):1240–67. doi: https://doi.org/10.6004/jnccn.2017.0156

  13. Dayyani F, Pettaway CA, Kamat AM, MunsellMF, Sircar K, Pagliaro LC. Retrospectiveanalysis of survival outcomes and the roleof cisplatin-based chemotherapy in patientswith urethral carcinomas referred to medicaloncologists. Urologic Oncology: Seminars andOriginal Investigations. 2013;31(7):1171–7. doi:https://doi.org/10.1016/j.urolonc.2012.01.011

  14. Zinman LN, Vanni AJ. Management ofProximal Primary Urethral Cancer: ShouldMultidisciplinary Therapy Be the GoldStandard? Urologic Clinics of North America.2016;43(4):505–13. doi: https://doi.org/10.1016/j.ucl.2016.06.011

  15. Sánchez de Badajoz E, Gallego Perales JL, RecheRosado A, Gutiérrez de la Cruz JM, JiménezGarrido A. Radical cystectomy and laparoscopicileal conduit. Arch Esp Urol. 1993;46(7):621–4.

  16. Matin SF, Gill IS. Laparoscopic RadicalCystectomy with Urinary Diversion: CompletelyIntracorporeal Technique. Journal ofEndourology. 2002;16(6):335–41. doi: https://doi.org/10.1089/089277902760261338

  17. Haber G-P, Campbell SC, Colombo JR,Fergany AF, Aron M, Kaouk J, et al.Perioperative outcomes with laparoscopicradical cystectomy: ‘pure laparoscopic’ and‘open-assisted laparoscopic’ approaches.Urology. 2007;70(5):910–5. doi: https://doi.org/10.1016/j.urology.2007.07.012




2020     |     www.medigraphic.com